Research Overview
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist being studied for metabolic research applications.
Key Research Findings
- Dual-action mechanism targeting both GIP and GLP-1 receptors
- Promising results in metabolic pathway studies
- Active area of ongoing research
For research use only. Not for human consumption.